Neuromuscular Blockade clinical trials at UCSF

• Comparison Of Rocuronium Reversal By Sugammadex To Succinylcholine For Electroconvulsive Therapy (ECT)

  open to eligible people ages 18 years and up

  The investigators propose to compare the recovery of neuromuscular blockade from rocuronium reversal by sugammadex to succinylcholine in ECT.

  San Francisco, California

Last updated: July 10, 2020